CN116983369A - A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method - Google Patents
A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method Download PDFInfo
- Publication number
- CN116983369A CN116983369A CN202311127461.0A CN202311127461A CN116983369A CN 116983369 A CN116983369 A CN 116983369A CN 202311127461 A CN202311127461 A CN 202311127461A CN 116983369 A CN116983369 A CN 116983369A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- herba
- traumatic hemorrhage
- treating traumatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010053476 Traumatic haemorrhage Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000012049 topical pharmaceutical composition Substances 0.000 title claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 16
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 11
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 11
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 11
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 11
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 11
- 239000009136 dragon's blood Substances 0.000 claims abstract description 11
- 239000010445 mica Substances 0.000 claims abstract description 11
- 229910052618 mica group Inorganic materials 0.000 claims abstract description 11
- 241000729173 Cirsium japonicum Species 0.000 claims abstract description 10
- 241000221079 Euphorbia <genus> Species 0.000 claims abstract description 10
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 10
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 241001598107 Imperata Species 0.000 claims description 12
- 241000233948 Typha Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 241000726221 Gemma Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 2
- 241000180649 Panax notoginseng Species 0.000 claims description 2
- 229940056582 human hair preparation Drugs 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000009286 sanguis draxonis Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 208000032843 Hemorrhage Diseases 0.000 abstract description 18
- 230000000740 bleeding effect Effects 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 10
- -1 sterol acetate Chemical class 0.000 abstract description 7
- 229930182558 Sterol Natural products 0.000 abstract description 5
- 235000003702 sterols Nutrition 0.000 abstract description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 abstract description 4
- 229930003935 flavonoid Natural products 0.000 abstract description 4
- 150000002215 flavonoids Chemical class 0.000 abstract description 4
- 235000017173 flavonoids Nutrition 0.000 abstract description 4
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 235000018553 tannin Nutrition 0.000 abstract description 4
- 239000001648 tannin Substances 0.000 abstract description 4
- 229920001864 tannin Polymers 0.000 abstract description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract description 3
- 150000007524 organic acids Chemical class 0.000 abstract description 3
- 229910052604 silicate mineral Inorganic materials 0.000 abstract description 3
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 abstract description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 abstract description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003658 monoterpene Natural products 0.000 abstract description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 abstract description 2
- 235000002577 monoterpenes Nutrition 0.000 abstract description 2
- 235000005875 quercetin Nutrition 0.000 abstract description 2
- 229960001285 quercetin Drugs 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000007171 Imperata cylindrica Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 10
- 238000001816 cooling Methods 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 2
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000967218 Selaginella tamariscina Species 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A pharmaceutical composition for external use for treating traumatic hemorrhage is a medicament prepared from the following pharmaceutical raw materials in parts by weight: 20-60 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 30-70 parts of nutgall, hairyvein agrimony, madder and mica respectively; 40-80 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 50-90 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively; in conclusion, the external pharmaceutical composition disclosed by the invention contains a plurality of trace elements such as flavonoids, m-benzene triphenols, monoterpenes, dandelion sterol acetate, organic acid, quercetin, tannins, silicate minerals and the like, has the effects of stopping bleeding, detumescence, sterilization, promoting granulation and relieving pain, can well treat traumatic hemorrhage, and has a synergistic effect after various medicinal materials are combined according to the formula proportion, the curative effect can be obviously improved, and the scientific proportioning is carried out on the dosage, so that the composition disclosed by the invention can play a role in treatment without worrying about side effects caused by the medicinal materials.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to an external pharmaceutical composition for treating traumatic hemorrhage and a preparation method thereof.
Background
Traumatic bleeding refers to external bleeding, which is usually caused by knife cuts, stabs, gun shots, rolling wounds, and the like, and is usually treated in hospitals, and the hemostatic method is different according to the type of bleeding. In the existing medicines for treating traumatic hemorrhage, the traditional Chinese medicines and the western medicines are used, but the defects of unobvious effect, slow wound healing, side effects caused by medicines and the like are common.
Disclosure of Invention
The invention aims to provide an external pharmaceutical composition for treating traumatic hemorrhage and a preparation method thereof, and solves the technical problems that the existing traditional Chinese medicine and western medicine are applied to treating traumatic hemorrhage, the wound healing is slow, and side effects are easy to cause.
In order to solve the technical problems, the invention adopts the following technical scheme:
a pharmaceutical composition for external use for treating traumatic hemorrhage is a medicament prepared from the following pharmaceutical raw materials in parts by weight:
20-60 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 30-70 parts of nutgall, hairyvein agrimony, madder and mica respectively; 40-80 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 50-90 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively.
Further, an external pharmaceutical composition for treating traumatic hemorrhage comprises the following raw materials in parts by weight:
30-50 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 40-60 parts of nutgall, hairyvein agrimony, madder and mica respectively; 50-70 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 60-80 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively.
Furthermore, the external pharmaceutical composition for treating traumatic hemorrhage has the same weight ratio of pollen typhae, herba seu radix Cirsii Japonici, herba Cephalanoploris and herba Selaginellae, the same weight ratio of Galla chinensis, herba et Gemma Agrimoniae, radix Rubiae and Muscovitum, the same weight ratio of Halloysitum rubrum, pulvis Fumi Carbonisatus, notoginseng radix and herba Euphorbiae Humifusae, and the same weight ratio of crinis Carbonisatus, lalang grass rhizome, os Sepiae and sanguis Draxonis.
Further, an external pharmaceutical composition for treating traumatic hemorrhage comprises the following raw materials in parts by weight: 40 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 50 parts of nutgall, hairyvein agrimony, madder and mica respectively; 60 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; each of the carbonized hair, the cogongrass rhizome, the cuttlebone and the dragon's blood is 70 parts.
Further, a pharmaceutical composition for external use for treating traumatic hemorrhage is in the form of powder, tablet, paste, tincture, pill or syrup.
A method for preparing an external pharmaceutical composition for treating traumatic hemorrhage, comprising the steps of: the preparation method comprises the steps of mixing the raw materials according to weight ratio, processing, drying, grinding to obtain powder, and preparing into topical pharmaceutical composition.
The external pharmaceutical composition is prepared according to the traditional Chinese medicine theory, and the dosage is scientifically proportioned, so that the composition can play a role in treatment without worrying about side effects caused by medicines, and meanwhile, the results of modern pharmacological research and clinical research show that the composition has definite curative effect and no side effects, and the chemical components of the selected pharmaceutical raw materials are as follows:
pollen Typhae: mainly comprises naringenin, typha saponin, steroid, polysaccharide and other components, has the effects of astringing to stop bleeding, activating blood and removing blood stasis;
radix seu herba Cirsii Japonici: mainly comprises components such as the salangid, the dandelion sterol acetate, the caryophyllene and the like, and has the effects of cooling blood, stopping bleeding, removing stasis and relieving swelling;
herba Cephalanoploris: mainly comprises rutin, linarin, protocatechuic acid, chlorogenic acid, caffeic acid, taraxacum sterol acetate and other components, and has the effects of cooling blood, stopping bleeding, removing blood stasis, detoxifying and eliminating carbuncles;
gallnut: mainly comprises tannins, gallic acid, fatty acid and other components, and has the effects of astringing lung to reduce fire, astringing intestines to check diarrhea, arresting sweating, stopping bleeding, and astringing dampness to arrest sore;
herba et Gemma Agrimoniae: mainly comprises flavonoid, phloroglucinol, agrimony lactone, tannins and other components, and has the effects of astringing to stop bleeding, checking malaria, stopping diarrhea, detoxifying and tonifying deficiency;
radix Rubiae: mainly comprises madder acid, alizarin, terpenes, polysaccharide, cyclopeptide compound and other components, and has the effects of cooling blood, removing blood stasis, stopping bleeding and dredging channels;
halloysitum rubrum: mainly comprises silicon aluminum tetrahydrate, ferric oxide and other components, has the effects of astringing intestines, stopping bleeding, promoting tissue regeneration and healing sore;
grass cream: has the effects of stopping bleeding, removing food retention, removing toxic substances, and clearing pathogenic fire;
residual carbon in blood: has effects in promoting granulation, healing wound, eliminating dampness, relieving swelling, and promoting wound healing;
herba Selaginellae: has effects of sexual pungent, antiinflammatory, hemostatic and repercussive;
lalang grass rhizome: mainly comprises imperatorin, arundoin, imperatorin, organic acid, sterol, saccharide and other components, and has the effects of cooling blood, stopping bleeding, clearing heat, promoting the production of body fluid, promoting urination and treating stranguria;
herba Euphorbiae Humifusae: mainly comprises flavonoid, coumarin, organic acid and other components, and has the effects of clearing heat and detoxicating, cooling blood and stopping bleeding, promoting diuresis and removing jaundice;
dragon's blood: mainly comprises the components of resina Draconis, flavanol, chalcone, abietic acid, mountain-answering pinoic acid and the like, and has the effects of activating blood circulation, relieving pain, removing blood stasis, stopping bleeding, promoting granulation and healing sore;
cuttlebone: mainly comprises calcium carbonate, sodium chloride, calcium phosphate and other components, and has the effects of astringing, stopping bleeding, astringing essence, stopping leukorrhagia, relieving hyperacidity, relieving pain, astringing dampness and promoting wound healing;
mica: mainly comprises silicate minerals, sodium, magnesium, lithium, iron and other trace elements, and can treat traumatic hemorrhage;
pseudo-ginseng: mainly comprises ginsenoside, notoginsenoside, esculin, tetracyclic triterpenes and other components, and has the effects of removing blood stasis, stopping bleeding, detumescence and relieving pain.
Compared with the prior art, the invention has the beneficial effects that: the external pharmaceutical composition disclosed by the invention contains a plurality of trace elements such as flavonoids, m-benzene triphenols, monoterpenes, dandelion sterol acetate, organic acids, quercetin, tannins, silicate minerals and the like, has the effects of stopping bleeding, detumescence, sterilization, promoting granulation and relieving pain, can well treat traumatic hemorrhage, has a synergistic effect after various medicinal materials are combined according to the formula proportion, can obviously improve the curative effect, and can be scientifically proportioned in dosage, so that the composition disclosed by the invention can play a role in treatment without worrying about side effects caused by the medicinal materials.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The present invention is described in further detail below with reference to examples.
Example 1: an external pharmaceutical composition for treating traumatic hemorrhage comprises the following raw materials in parts by weight: 35 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 50 parts of nutgall, hairyvein agrimony, madder and mica respectively; 55 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 66 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively;
the preparation method comprises the steps of mixing the above raw materials according to weight ratio, processing, drying, grinding to obtain powder, and making into topical pharmaceutical composition.
Example 2: an external pharmaceutical composition for treating traumatic hemorrhage comprises the following raw materials in parts by weight: 40 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 50 parts of nutgall, hairyvein agrimony, madder and mica respectively; 60 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 70 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively;
the preparation method comprises the steps of mixing the above raw materials according to weight ratio, processing, drying, grinding to obtain powder, and making into topical pharmaceutical composition.
Example 3: an external pharmaceutical composition for treating traumatic hemorrhage comprises the following raw materials in parts by weight: 60 parts of cattail pollen, japanese thistle, herba Cephalanoploris and selaginella tamariscina respectively; 70 parts of nutgall, hairyvein agrimony, madder and mica respectively; 80 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; the raw materials comprise 90 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood.
In order to better verify the curative effect of the external-use pharmaceutical composition of the invention, the beneficial effects of the external-use pharmaceutical composition of the invention on traumatic hemorrhage are illustrated by the following clinical observation data.
Case 1: long Mou women, 8 years old, have more blood flow and severe pain due to careless impact of stones on the forehead; the wound is cleaned and disinfected after being pressed for a while, the traditional Chinese medicine is externally applied to an affected part and is wrapped, and then blood flow is stopped immediately, so that pain is relieved; after 5 days the wound healed completely and was scarred.
Case 2: hu Mou when a man, 60 years old, walks carelessly and slips down in rainy days, so that the right arm and the belt meat are scratched off by stones, the wound is about 5cm long and about 3cm wide, the blood flow is more than, the pain is severe, after the bleeding of the wound is relieved by pressing, the wound is immediately cleaned and disinfected, the traditional Chinese medicine is externally applied and wrapped, the blood flow is reduced, and the blood flow is stopped after about 5 minutes, so that the pain is relieved; the wound heals after 4 days, and the wound is scarred after 5 days, and the scar is small.
Case 3: zhao Mou when a man is 50 years old, the sole of the man is carelessly pricked by nails during sundries collection, the blood flow is not only stable, but the man is painful and can not walk when the nails are pulled out; the wound is cleaned immediately, and then the traditional Chinese medicine is applied to the affected part and wrapped, so that the blood flow is reduced, and the pain is relieved; after 5 days, the wound heals well, but the finger is pressed on the affected part to feel slight pain, the wound is scarred after 3 days, the affected part has no pain, and the walking is free.
Case 4: zhang Mou when a man is 30 years old, the man cuts the food from 1/4 of the 1 st joint of the left index finger carelessly during cutting, so that the blood flow is not only severe, the pain is severe, the cut finger is reset and fixed immediately, and the traditional Chinese medicine is wrapped, so that the blood flow is slowly reduced, and the pain is relieved; after 10 days, the fingers are well combined, the broken fingers can slightly bounce, and after 3 days, the wound heals the scar, and the fingers can freely move.
It should be noted that in this document, terms such as "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. The external medicine composition for treating traumatic hemorrhage is characterized by being prepared from the following medicine raw materials in parts by weight:
20-60 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 30-70 parts of nutgall, hairyvein agrimony, madder and mica respectively; 40-80 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 50-90 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively.
2. The external pharmaceutical composition for treating traumatic hemorrhage according to claim 1, wherein the weight ratio of the raw materials of the medicine is:
30-50 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 40-60 parts of nutgall, hairyvein agrimony, madder and mica respectively; 50-70 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; 60-80 parts of carbonized hair, cogongrass rhizome, cuttlebone and dragon's blood respectively.
3. The external pharmaceutical composition for treating traumatic hemorrhage according to claim 1, wherein the weight ratio of pollen typhae, herba seu radix Cirsii Japonici, herba Cephalanoploris and herba Selaginellae is the same, the weight ratio of Galla chinensis, herba et Gemma Agrimoniae, radix Rubiae and Muscovitum is the same, halloysitum rubrum, pulvis Fumi Carbonisatus, notoginseng radix and herba Euphorbiae Humifusae is the same, and crinis Carbonisatus, lalang grass rhizome, os Sepiae and sanguis Draxonis are the same.
4. The external pharmaceutical composition for treating traumatic hemorrhage according to claim 3, wherein the weight ratio of the raw materials of the drugs is: 40 parts of cattail pollen, japanese thistle, herba Cephalanoploris and herba selaginellae; 50 parts of nutgall, hairyvein agrimony, madder and mica respectively; 60 parts of red halloysite, pulvis Fumi Carbonisatus, pseudo-ginseng and humifuse euphorbia herb respectively; each of the carbonized hair, the cogongrass rhizome, the cuttlebone and the dragon's blood is 70 parts.
5. The pharmaceutical composition for external use for treating traumatic hemorrhage according to any one of claims 1 to 4, wherein the dosage form of the pharmaceutical composition for external use is a powder, a tablet, a paste, a tincture, a pill or a syrup.
6. A method of preparing a topical pharmaceutical composition for treating traumatic hemorrhage, comprising the steps of: the preparation method comprises the steps of mixing the raw materials according to weight ratio, processing, drying, grinding to obtain powder, and preparing into topical pharmaceutical composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311127461.0A CN116983369A (en) | 2023-09-04 | 2023-09-04 | A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311127461.0A CN116983369A (en) | 2023-09-04 | 2023-09-04 | A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116983369A true CN116983369A (en) | 2023-11-03 |
Family
ID=88523260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311127461.0A Pending CN116983369A (en) | 2023-09-04 | 2023-09-04 | A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116983369A (en) |
-
2023
- 2023-09-04 CN CN202311127461.0A patent/CN116983369A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN103705735A (en) | Traditional Chinese medicine powder for stopping bleeding and diminishing inflammation | |
| CN103933285B (en) | A kind of traditional Chinese medicine for oral administration prescription that can accelerate postop fracture healing | |
| CN116983369A (en) | A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method | |
| CN1051236C (en) | Styptic powder | |
| CN108498617A (en) | Rheumatalgia Chinese medicine composition and its preparation method and application, lavipeditum packet and preparation method thereof and pharmaceutical preparation | |
| CN103977266B (en) | Dendrobium officinale traditional Chinese medicine composition for hemostasis | |
| CN105687363B (en) | A kind of Chinese medicine and its preparation method and application for treating traumatic hemorrhage | |
| CN101491626B (en) | Traditional Chinese medicine composition for treating skin injury and pyogenic infection | |
| CN108066466A (en) | A kind of Chinese medicine composition for treating burn and scald and preparation method and application | |
| CN111419952B (en) | Traditional Chinese medicine composition with hemostatic and analgesic effects and preparation method and application thereof | |
| CN104491462B (en) | A kind of pharmaceutical composition for the treatment of scald | |
| CN105560343A (en) | Traditional Chinese medicine composition for treating neonatal omphalitis | |
| CN107536937A (en) | A kind of external application Chinese medicine decoction for treating skin disease and onychomycosis and preparation method thereof | |
| CN107041919A (en) | A kind of hemorrhoid, ointment for burns and scalds and preparation method thereof | |
| CN106474439A (en) | A kind of have heat-clearing and toxic substances removing, the Chinese medicinal ointment of removing heat from blood and promoting blood circulation function and preparation method thereof | |
| CN107050233A (en) | A kind of Chinese medicine paste formulation and preparation method for treating diabetes skin damaged | |
| CN104306772A (en) | Traditional Chinese medicine composition for treating radiodermatitis and preparation method of traditional Chinese medicine composition | |
| CN111329941A (en) | Traditional Chinese medicine composition for treating fracture injury and preparation and application thereof | |
| CN107050298A (en) | A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged | |
| CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
| CN112717019A (en) | Traditional Chinese medicine composition for treating pyocutaneous disease and preparation method thereof | |
| CN110742967A (en) | Medicine for treating burns, scalds and diabetic feet and application thereof | |
| CN108514596A (en) | A kind of Chinese medicine composition and preparation method for treating treating rheumatic ostealgia | |
| CN104147366A (en) | External ointment for curing burns, scalds and carbuncles and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |